Device / Technology News

RSS

Varian launches on-line X-ray product finder tool

Varian Medical Systems, X-Ray Products, has launched an on-line product finder tool giving customers the ability to quickly locate needed replacement X-ray tubes as well as flat panel detectors for digital imaging.

26 Jun 2012

First handbook on microcirculation imaging techniques

Microcirculation Imaging is the first handbook of its kind, introducing many different technical approaches for the visualization of microcirculation. Clearly structured throughout, this book is a must for every clinician and researcher relying on microcirculation imaging.

26 Jun 2012

Merck Serono, Compugen announce establishment of Neviah Genomics

Merck Serono, a division of Merck, Darmstadt, Germany, and Compugen Ltd. today announced the establishment of Neviah Genomics, a novel start-up company focused on the discovery and development of novel biomarkers for the prediction of drug-induced toxicity.

26 Jun 2012

Beckman Coulter announces PMA from FDA for Prostate Health Index

Beckman Coulter, Inc., the leader in prostate cancer diagnostics, announces Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Prostate Health Index (phi), a simple, non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than PSA (prostate-specific antigen) in patients with PSA values in the 4-10 ng/mL range and is proven to reduce the number of prostate biopsies.

From Beckman Coulter Diagnostics 26 Jun 2012

Clinical study to examine retrograde tibiopedal interventional approach for CLI

Clinical investigators are for the first time examining the retrograde tibiopedal interventional approach, an endovascular technique that has the potential to reduce the rate of leg amputations by as much as 50 percent in patients with critical limb ischemia (CLI), a manifestation of peripheral arterial disease (PAD).

26 Jun 2012

Researchers develop inexpensive system that offers benefits of cardiac rehabilitation programmes

Researchers at the Universidad Poltécnica de Madrid (UPM) have developed an inexpensive system that offers the benefits of cardiac rehabilitation programmes for patients who currently cannot access them.

26 Jun 2012

New system provides comprehensive remote monitoring solution for the chronically ill

As Europe's population ages, chronic diseases are becoming increasingly widespread. Characterised by gradually deteriorating health and recurring incidents often requiring immediate medical attention, chronic illnesses have a severe impact on patients' autonomy and life quality and are putting increasing strain on over-stretched healthcare systems.

26 Jun 2012

NIH awards SeKON contract under CIO-SP3 restricted solicitation

SeKON Enterprise, Inc., a leader in enterprise business applications and management consulting, announced today that the National Institutes of Health (NIH) has awarded the company a contract under its Chief Information Officer - Solutions and Partners 3 (CIO-SP3) restricted solicitation.

25 Jun 2012

Enrollment commences in Stealth Peptides' Bendavia Phase II clinical study for acute STEMI

Stealth Peptides Incorporated, a privately held biopharmaceutical company developing innovative therapies for cardiovascular disease and its complications, announced today that the first patient was enrolled in its multinational Phase II clinical study with Bendavia focused on ischemia reperfusion and microvascular injuries for patients experiencing acute ST-segment elevation myocardial infarction.

25 Jun 2012

Vasomedical subsidiary amends sales representative agreement with GE Healthcare

Vasomedical, Inc. a diversified medical technology company specializing in the design, manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products, today announces the amendment of the sales representative agreement between its subsidiary, Vaso Diagnostics Inc. d/b/a Vaso Healthcare and GE Healthcare, the healthcare business unit of GE, originally signed on May 19, 2010.

25 Jun 2012

New test can identify low-risk thyroid nodules and reduce unnecessary surgeries

A new test can be used to identify low-risk thyroid nodules, reducing unnecessary surgeries for people with thyroid nodules that have indeterminate results after biopsy. The results of the multi-center trial, which includes researchers from the Perelman School of Medicine at the University of Pennsylvania, appear online in the New England Journal of Medicine.

25 Jun 2012

Afirma gene expression test can reduce unnecessary thyroid cancer surgeries

Veracyte, Inc., a molecular diagnostics company that is pioneering the emerging field of molecular cytology, today announced results from a large, prospective, multicenter study, which demonstrated the potential for the Afirma® Gene Expression Classifier, a gene expression test, to reduce the large number of unnecessary surgeries in thyroid cancer diagnosis by more than half.

25 Jun 2012

Thomson Reuters unveils new regulatory intelligence solution at DIA 2012

The Intellectual Property & Science division of Thomson Reuters unveiled Cortellis for Regulatory Intelligence™ at the DIA 2012 Annual Meeting in Philadelphia today. This new offering is the next generation of Thomson Reuters IDRAC™, the company's best-in-class regulatory intelligence tool that provides pharmaceutical professionals with reliable and accurate global regulatory information to gain competitive advantage and minimize regulatory risks.

25 Jun 2012

Philips selects Acuo as partner for multi-site federated vendor neutral archive in UK

Acuo Technologies, the world leader in high-performance software and services for clinical content management and data migration, announced today it has been selected as the preferred supplier to work with technology partner and prime contractor Philips in the United Kingdom to implement a multi-site federated vendor neutral archive, featuring fully-distributed data management with centralized administration, to be shared across six NHS trusts in Surrey and Sussex.

25 Jun 2012

Comprehensive, automated infection outbreak detection system for the Olympics

The world's first comprehensive, automated outbreak detection system which will monitor over 3,000 infections and is ready to run during Olympics 2012, was developed by a researcher at The Open University.

25 Jun 2012

Mount Sinai offers transoral robotic surgery for sleep apnea treatment

The Center for Minimally Invasive and Robotic Surgery at The Mount Sinai Medical Center—a pioneer in robotic surgery—now offers the procedure to patients with sleep apnea, whose obstructive breathing prevents them from sleeping normally. Mount Sinai is one of only a few programs in the world to use transoral robotic surgery (TORS) to remove excess tissue or fix a collapsed airway that causes sleep apnea.

25 Jun 2012

Self-harm and suicide in young people: the role of new media

In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford’s Centre for Suicide Research, and Professor Rory O’Connor of University of Stirling’s Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.

25 Jun 2012

New service known as ‘Senior Care’ provided by Intamac Systems

Intamac Systems Limited, the B2B Connected Home service provider announces the release of a new and improved ‘Senior Care’ service.

25 Jun 2012

iWorx launches IX-100BE Data Acquisition System with LabScribe2 Software

iWorx, a developer of advanced physiology research tools, has introduced the IX-100BE Data Acquisition System with LabScribe2 Software that provides high resolution/low noise recording of biopotential signals for OEM applications.

25 Jun 2012

Cell-free, biodegradable artery graft improves coronary artery bypass surgeries

With the University of Pittsburgh's development of a cell-free, biodegradable artery graft comes a potentially transformative change in coronary artery bypass surgeries: Within 90 days after surgery, the patient will have a regenerated artery with no trace of synthetic graft materials left in the body.

25 Jun 2012